Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. - Wikidata - thesis-toulmin - TriplyDB

Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer.

Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer.

http://www.wikidata.org/entity/Q38326633

about

The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications Dysregulation of non-coding RNAs in gastric cancer Clinical application of microRNA in gastric cancer in Eastern Asian area Regulation of mesenchymal phenotype by MicroRNAs in cancer The functional sites of miRNAs and lncRNAs in gastric carcinogenesis Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer PRC2/EED-EZH2 complex is up-regulated in breast cancer lymph node metastasis compared to primary tumor and correlates with tumor proliferation in situ Dysregulation of uterine signaling pathways in progesterone receptor-Cre knockout of dicer.Role of epithelial-mesenchymal transition in gastric cancer initiation and progression MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma Genomic profile analysis of diffuse-type gastric cancers Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.MicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatin Identification of microRNA-mRNA functional interactions in UVB-induced senescence of human diploid fibroblasts A systematic review of microRNA expression profiling studies in human gastric cancer.Insulin/IGF-I signaling pathways enhances tumor cell invasion through bisecting GlcNAc N-glycans modulation. an interplay with E-cadherin.microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer.Dynamic microRNA-101a and Fosab expression controls zebrafish heart regeneration Functional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathways.Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma miR-148a downregulates the expression of transforming growth factor-β2 and SMAD2 in gastric cancer microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia CPEB1, a histone-modified hypomethylated gene, is regulated by miR-101 and involved in cell senescence in glioma The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression.Akt-p53-miR-365-cyclin D1/cdc25A axis contributes to gastric tumorigenesis induced by PTEN deficiency The role of microRNAs in cancers of the upper gastrointestinal tract.Genetic variations in the flanking regions of miR-101-2 are associated with increased risk of breast cancer.Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers.miR-101 inhibits cell proliferation by targeting Rac1 in papillary thyroid carcinoma.Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway.Role of microRNAs in gastric cancer.miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies.The microRNA-423-3p-Bim Axis Promotes Cancer Progression and Activates Oncogenic Autophagy in Gastric Cancer.miR-564 is downregulated in gastric carcinoma and targets E2F3.MiR-203 inhibits tumor invasion and metastasis in gastric cancer by ATM.Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer.Circulatory miR-628-5p is downregulated in prostate cancer patients.Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells.Digital PCR identifies changes in CDH1 (E-cadherin) transcription pattern in intestinal-type gastric cancer.

P2860

Q26779166-AB4C7FCD-623E-4A74-830C-28A0E8867229 Q26780293-8D8094BC-8256-4468-B2A8-EFEFCD292A48 Q26829583-A11AE18A-7995-4C27-97D7-AFD671C23765 Q27009506-458463F9-49F2-4FFD-9F00-405DC06B8A81 Q27026837-F75AB72C-4F52-4E00-BAD0-3E2D08C57EC8 Q28082679-B752B2A6-C04F-4617-A1BF-4F6AC75AFE7B Q28484272-376524F6-8E38-4DD7-B2C7-32F51CC0C16E Q30417482-3452DB2C-2E94-4946-AF06-30757F78D6A4 Q33594912-8E6D4A9C-468B-45CE-8DD7-54827295C921 Q33609359-A0D9D938-6412-4C30-A4FF-D633E2B93950 Q33751124-6A4F8908-7A66-4450-9584-333F449D0A04 Q34028475-0F7799D6-BD91-4125-AEFE-52FB701863DF Q34093885-6BE8826B-0923-4201-BA61-C811775DF958 Q34655450-69B803E7-4EA4-4306-B3EF-10D260F3692B Q35000434-0DBF3806-97F6-454C-BBCA-C0172503F2EE Q35055368-1AAC9585-89CD-4456-9335-007CD54CCB05 Q35793647-427CDEDD-B90D-45D2-A2C8-A30313C693D4 Q36462531-CF57B2C2-0458-4E69-86EB-0809F538B31E Q36540471-9E7A0CC2-E072-4D83-9049-9AAC947DC909 Q36545009-1CEC6A0A-5347-44A6-8E54-4D1D6658BA6C Q36734201-7F9FDEAC-A3B6-4FEF-A21E-72DF46D23EEC Q36946773-C8EBBF42-CF3B-4DB5-BCD8-9E943BC3BCB9 Q36985123-1D408D30-BACB-4A5A-AAEE-0C954BD24663 Q37022273-F5430AA6-BAA6-435E-A9C4-C96FBE77EDB0 Q37251389-0F32B61C-33EE-4972-9C12-3B004C8F7F77 Q37305250-B56601A6-6179-4D84-AE8E-7ADFD8A6DA83 Q37374880-363159F0-8824-4E3F-B1D8-440CE9B5323B Q37514266-0D825B5A-0A7A-44DF-8019-D7D7AAF41F88 Q37537123-C4B44503-0894-403E-ACD9-CDFB01066CBA Q37565598-CBC3D5E3-3A65-42A6-AA8C-E1868A94588F Q37602508-40825AC7-8FFC-4678-87C0-9C2637163E18 Q38219019-09459FDD-7721-4CCA-9E5D-F4CEF077ABBE Q38476564-AA76DEA1-CA07-4FF2-B5FE-E719A89684D4 Q38714103-2ACB7C63-E4F0-4501-B47A-7AD07BB81FB4 Q38739532-9B4A4256-95F2-4355-85AD-123D699DFC89 Q38751011-1400ACB1-5CDC-472C-8221-A8AB64924079 Q39035829-CF3D7E55-E859-4CED-98CE-63E2BB84FEF7 Q39260664-E3F35CC7-8239-454F-BD1E-F59B01DD8689 Q39289136-8F6834C3-7951-4AA7-A80B-6E058B6B6AC3 Q40421665-8D233133-5C4D-4562-87F0-134568869308

P2860

Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer.

http://www.wikidata.org/entity/Q38326633

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Lack of microRNA-101 causes E- ...... in intestinal gastric cancer.

@en

Lack of microRNA-101 causes E- ...... in intestinal gastric cancer.

@en-gb

type

label

Lack of microRNA-101 causes E- ...... in intestinal gastric cancer.

@en

Lack of microRNA-101 causes E- ...... in intestinal gastric cancer.

@en-gb

prefLabel

Lack of microRNA-101 causes E- ...... in intestinal gastric cancer.

@en

Lack of microRNA-101 causes E- ...... in intestinal gastric cancer.

@en-gb

P1433

Q38326633-1216640C-F075-4FB3-BF31-C3E0FB0FEF2E

P1476

Q38326633-BF53D3D8-E694-46B2-BF96-972ADA8D6888

P2093

Q38326633-317413EC-8758-4137-82F7-F311AA17081F

Q38326633-5F351969-2BFE-4499-AF32-17E484DD0931

Q38326633-B35A183F-B55D-4BC1-8B18-674863DF8283

Q38326633-BA79D62C-C5D6-44AC-8505-B70DE1E0621F

Q38326633-BA8FA32F-3F93-48AC-A780-CC5DFA69B32C

Q38326633-C9B895D9-EDF1-408B-BC2C-0F502A622965

Q38326633-CBE13022-A271-4B0A-A1E2-5C505B35E551

Q38326633-F1471784-F9A8-47FA-824A-5E05D7C40E22

P2860

Q38326633-00E6E435-2296-4494-9995-D5E4D07C2EC9

Q38326633-0626D037-676C-404A-A404-C3B5F79548D0

Q38326633-0D60A2A2-E6F4-4A4F-B0F3-BE637C12AFFC

Q38326633-0FBB4B2B-367B-4DE8-9788-94E61A50F3FD

Q38326633-19D9EC2A-64EC-4FBE-9A0F-57CAE07B1599

Q38326633-25157D24-E983-4D08-90BC-1B709BFDED60

Q38326633-262F7B67-5251-4375-8825-D41242DA5E47

Q38326633-264C3997-48FD-4A8D-92DA-822B29F97D32

Q38326633-2E6C24BF-A47A-41EA-B550-BD492287657A

Q38326633-31B32128-E75D-4DB5-B074-792871312847

P304

Q38326633-5C36D141-16FB-40D0-A30D-A9A413ADF2D5

P31

Q38326633-77C5685F-A42B-462A-A390-0C36484AE6E2

P356

Q38326633-83DE28B8-0D48-4CD7-937B-572408C186D0

P433

Q38326633-7488056A-DF15-43AC-9DBF-A0AF9A917F38

P478

Q38326633-4C210761-815A-4DA1-88F7-8EB5739776EE

P50

Q38326633-46BBBC66-2D4D-41DA-97AF-8A73CD669190

Q38326633-6341FC6C-A3A5-41DC-A448-9F5483CADB30

Q38326633-A87AEC99-5D3A-42C5-9B17-4EE78737C3E9

Q38326633-C3A2B16C-8176-4EAE-9181-0E1E9ABC26D3

Q38326633-DC5A03E8-4994-4649-8AC4-8ED02B92D7C6

P577

Q38326633-7F458982-6828-4DF1-B77F-BBDD3827A706

P5875

Q38326633-485417F7-D772-4134-96CB-8CEEA010A47C

P698

Q38326633-DF5FB84C-6A91-4F49-8D3D-08E01571C7D6

P921

Q38326633-FCD3CE19-8DBE-4EA4-8A19-39751F008184

P356

P1433

The Journal of Pathology

P1476

Lack of microRNA-101 causes E- ...... in intestinal gastric cancer.

@en

P2093

Beatriz Carvalho

http://www.w3.org/2001/XMLSchema#string

Begoña Diosdado

http://www.w3.org/2001/XMLSchema#string

Gerrit Meijer

http://www.w3.org/2001/XMLSchema#string

Manuel A S Santos

http://www.w3.org/2001/XMLSchema#string

Marianne Tijssen

http://www.w3.org/2001/XMLSchema#string

Nicole C van Grieken

http://www.w3.org/2001/XMLSchema#string

Sónia Sousa

http://www.w3.org/2001/XMLSchema#string

Tineke E Buffart

http://www.w3.org/2001/XMLSchema#string

P2860

miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis

Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes.

Global cancer statistics, 2002

Role of histone H3 lysine 27 methylation in Polycomb-group silencing

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

The polycomb group protein EZH2 is involved in progression of prostate cancer

MicroRNA expression variability in human cervical tissues

Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas.

P304

31-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PATH.4032

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

228

http://www.w3.org/2001/XMLSchema#string

P50

Heike Irmgard Grabsch

Patrícia M Pereira

P577

2012-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221982265

http://www.w3.org/2001/XMLSchema#string

P698

22450781

http://www.w3.org/2001/XMLSchema#string

P921